返回 Agenda
Am I impacted by BREXIT ?
Session Chair(s)
Vicki Edwards, RPH
Vice President, Pharmacovigilance Excellence and International QPPV, Abbvie, United Kingdom
Brian Edwards, DrMed
Director, International Society of Pharmacovigilance, United Kingdom
This session will address some of the uncertainty surrounding the QPPV role and Brexit. What are practical implications of Brexit for UK based QPPVs? What is the impact for MAHs if QPPV moves and the team remains UK based? What is the legal situation concerning the definition ‘reside and operate in the EU? Does this mean meeting rules for residency rather than just ‘work out of’? Will there be an impact on the deputy QPPV (or ‘back-up’)? These questions and more we’ll try and answer in what promises to be a lively discussion.
Speaker(s)
Mick Foy
Director of Delivery, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Tim Sarson
Partner, Life Sciences Lead for Brexit, KPMG, United Kingdom
Turning Confusing Political Scenarios into Workable Plans
Vicki Edwards, RPH
Vice President, Pharmacovigilance Excellence and International QPPV, Abbvie, United Kingdom
Elspeth McIntosh, MBA, RN
Director, Castle Pharmacovigilance Ltd, United Kingdom